Cargando…
Biochemical prediction of response of bone metastases to treatment.
Assessment of response of skeletal metastases to systemic therapy is currently dependent on radiological evidence of bone healing. We have performed a prospective study of additional response criteria in patients with progressive bone metastases from breast cancer. Changes in these potential markers...
Autores principales: | Coleman, R. E., Whitaker, K. B., Moss, D. W., Mashiter, G., Fogelman, I., Rubens, R. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246751/ https://www.ncbi.nlm.nih.gov/pubmed/3262366 |
Ejemplares similares
-
The clinical course of bone metastases from breast cancer.
por: Coleman, R. E., et al.
Publicado: (1987) -
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
por: Coleman, R. E., et al.
Publicado: (1988) -
Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients
por: Morcos, Nadia YS, et al.
Publicado: (2013) -
The Use of Massive Endoprostheses for the Treatment of Bone Metastases
por: Park, D. H., et al.
Publicado: (2007) -
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)